These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7034156

  • 1. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR, Ebert R, Creutzfeldt W.
    Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
    [Abstract] [Full Text] [Related]

  • 2. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J, Kemmer F, Morishima T, Berchtold P, Vranic M.
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [Abstract] [Full Text] [Related]

  • 3. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
    Hillebrand I, Aubell R, Boehme K, Bloom SR, Berchtold P.
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term effects of intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in diabetics on sulphonylureas.
    Uttenthal LO, Ukponmwan OO, Wood SM, Ghiglione M, Ghatei MA, Trayner IM, Bloom SR.
    Diabet Med; 1986 Mar; 3(2):155-60. PubMed ID: 2951158
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.
    Seifarth C, Bergmann J, Holst JJ, Ritzel R, Schmiegel W, Nauck MA.
    Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP, Keup U, Puls W.
    Digestion; 1982 Jun; 23(4):232-8. PubMed ID: 6754513
    [Abstract] [Full Text] [Related]

  • 11. Combined use of guar and acarbose in reduction of postprandial glycaemia.
    Jenkins DJ, Taylor RH, Nineham R, Goff DV, Bloom SR, Sarson D, Alberti KG.
    Lancet; 1979 Nov 03; 2(8149):924-7. PubMed ID: 91023
    [Abstract] [Full Text] [Related]

  • 12. A glycoside-hydrolase inhibitor in treatment of dumping syndrome.
    McLoughlin JC, Buchanan KD, Alam MJ.
    Lancet; 1979 Sep 22; 2(8143):603-5. PubMed ID: 90270
    [Abstract] [Full Text] [Related]

  • 13. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.
    Ebert R, Arnold R, Creutzfeldt W.
    Gut; 1977 Feb 22; 18(2):121-7. PubMed ID: 856672
    [Abstract] [Full Text] [Related]

  • 14. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R, Frerichs H, Creutzfeldt W.
    Eur J Clin Invest; 1979 Apr 22; 9(2 Pt 1):129-35. PubMed ID: 111943
    [Abstract] [Full Text] [Related]

  • 15. [Acarbose--a new therapeutic principle in diabetes mellitus therapy].
    Schöffling K, Hillebrand I.
    Dtsch Med Wochenschr; 1981 Aug 28; 106(35):1083-4. PubMed ID: 6114844
    [No Abstract] [Full Text] [Related]

  • 16. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.
    Hillebrand I, Boehme K, Frank G, Fink H, Berchtold P.
    Res Exp Med (Berl); 1979 Apr 23; 175(1):87-94. PubMed ID: 375343
    [Abstract] [Full Text] [Related]

  • 17. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect.
    Ranganath L, Norris F, Morgan L, Wright J, Marks V.
    Diabet Med; 1998 Feb 23; 15(2):120-4. PubMed ID: 9507911
    [Abstract] [Full Text] [Related]

  • 18. alpha-Glucosidase inhibition in obesity.
    William-Olsson T.
    Acta Med Scand Suppl; 1985 Feb 23; 706():1-39. PubMed ID: 3914827
    [Abstract] [Full Text] [Related]

  • 19. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose).
    Qualmann C, Nauck MA, Holst JJ, Orskov C, Creutzfeldt W.
    Scand J Gastroenterol; 1995 Sep 23; 30(9):892-6. PubMed ID: 8578189
    [Abstract] [Full Text] [Related]

  • 20. Blood insulin, glucose, fructose and gastric inhibitory polypeptide levels in carbohydrate-sensitive and normal men given a sucrose or invert sugar tolerance test.
    Ellwood KC, Michaelis OE, Hallfrisch JG, O'Dorisio TM, Cataland S.
    J Nutr; 1983 Sep 23; 113(9):1732-6. PubMed ID: 6350543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.